MyFinsight
Home
About
Contact
vir: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, VIR has $1,019,453K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
1,019,453
1,192,532
Total stockholders equity
796,098
947,472
Total liabilities and stockholders equity
1,019,453
1,192,532
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$36,956K
Equity investments
$8,679K
Restricted cash and cash
equivalents, current
$2,215K
Short-term investments
$327,750K
Cash and cash
equivalents
$170,084K
Other assets
$15,981K
Long-term investments
$304,212K
Restricted cash and cash
equivalents, noncurrent
$6,957K
Operating lease
right-of-use assets
$63,555K
Property and equipment,
net
$58,203K
Goodwill
$16,937K
Intangible assets, net
$7,924K
Total current assets
$545,684K
Total assets
$1,019,453K
Total liabilities and
stockholders equity
$1,019,453K
Total stockholders
equity
$796,098K
Total liabilities
$223,355K
Accumulated deficit
-$1,154,848K
Accumulated other
comprehensive loss
-$1,911K
Additional paid-in capital
$1,952,843K
Other long-term
liabilities
$13,305K
Contingent consideration
obligation, noncurrent
$34,180K
Operating lease
liabilities, noncurrent
$91,215K
Deferred revenue,
noncurrent
$9,433K
Total current
liabilities
$75,222K
Common stock, 0.0001
par value...
$14K
Accrued and other
liabilities
$68,375K
Accounts payable
$6,847K
Subscribe for Financial Insights
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR)